Evidence map›Paper›PMID 37047205›Full record

ArticleInternational journal of molecular sciences2023

Thiosulfinate-Enriched

José Avendaño-Ortiz, Francisco Javier Redondo-Calvo, Roberto Lozano-Rodríguez, Verónica Terrón-Arcos, Marta Bergón-Gutiérrez, Concepción Rodríguez-Jiménez, Juan Francisco Rodríguez, Rosa Del Campo, Luis Antonio Gómez, Natalia Bejarano-Ramírez and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

José Avendaño-OrtizDepartment of Microbiology, University Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Francisco Javier Redondo-CalvoDepartment of Anesthesiology and Critical Care Medicine, University General Hospital, 13004 Ciudad Real, Spain.ORCID 0000-0002-7044-0154
Roberto Lozano-RodríguezThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0003-0093-9707
Verónica Terrón-ArcosThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Marta Bergón-GutiérrezThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Concepción Rodríguez-JiménezDepartment of Microbiology, University Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Juan Francisco RodríguezDepartment of Chemical Engineering, Institute of Chemical and Environmental Technology, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.ORCID 0000-0001-8838-1976
Rosa Del CampoDepartment of Microbiology, University Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-1147-7923
Luis Antonio GómezDepartment of Chemical Engineering, Institute of Chemical and Environmental Technology, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.
Natalia Bejarano-RamírezTranslational Research Unit, University General Hospital and Research Institute of Castilla-La Mancha (IDISCAM), 13071 Ciudad Real, Spain.
José Manuel Pérez-OrtizTranslational Research Unit, University General Hospital and Research Institute of Castilla-La Mancha (IDISCAM), 13071 Ciudad Real, Spain.ORCID 0000-0002-3588-6273
Eduardo López-CollazoThe Innate Immune Response Group, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Instituto de Salud Carlos III · ESUniversity of Castilla-La Mancha · ESHospital General Universitario de Ciudad Real · ESInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

MU-OPIOID AND ALPHA2-ADRENERGIC MECHANISMS IN ANALGESIAR01DA007212 · NIDA · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SIREN, ANNA-LEENA K · 1991 to 1993
–
Comunidad de Madrid P2022/BMD-7212Instituto de Salud Carlos III CB06/02/0053Instituto de Salud Carlos III CD21/00059
6 · The paper itself

Abstract

Garlic (

Indexed as

GarlicSepsisAntioxidantsHumansHypoxia-Inducible Factor 1, alpha SubunitLipopolysaccharidesMonocytesTumor Necrosis Factor-alphaAntioxidantsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitLipopolysaccharidesTumor Necrosis Factor-alphaallicinAllium sativumendotoxin tolerancegarlic extractimmunomodulationinflammationsepsisthiosulfinates

Identifiers

PMID37047205
PMCPMC10094690
OpenAlexW4361007702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.